Annual EBITDA
-$5.45 M
+$6.87 M+55.77%
31 December 2023
Summary:
Virios Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$5.45 million, with the most recent change of +$6.87 million (+55.77%) on 31 December 2023. During the last 3 years, it has risen by +$4.56 million (+45.56%). VIRI annual EBITDA is now -177.69% below its all-time high of -$1.96 million, reached on 31 December 2018.VIRI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.30 M
-$1.23 M-115.10%
30 September 2024
Summary:
Virios Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.30 million, with the most recent change of -$1.23 million (-115.10%) on 30 September 2024. Over the past year, it has dropped by -$1.03 million (-80.58%). VIRI quarterly EBITDA is now -501.46% below its all-time high of -$382.60 thousand, reached on 31 March 2020.VIRI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$5.82 M
-$1.03 M-21.41%
30 September 2024
Summary:
Virios Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$5.82 million, with the most recent change of -$1.03 million (-21.41%) on 30 September 2024. Over the past year, it has increased by +$575.33 thousand (+8.99%). VIRI TTM EBITDA is now -1073.79% below its all-time high of -$496.10 thousand, reached on 30 June 2019.VIRI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.8% | -80.6% | +9.0% |
| 3 y3 years | +45.6% | +44.0% | +67.4% |
| 5 y5 years | -177.7% | -212.5% | -372.5% |
VIRI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +65.2% | -115.1% | +45.0% | -21.4% | +67.4% |
| 5 y | 5 years | -177.7% | +65.2% | -501.5% | +64.2% | -372.5% | +67.4% |
| alltime | all time | -177.7% | +65.2% | -501.5% | +64.2% | -1073.8% | +67.4% |
Virios Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.30 M(+115.1%) | -$5.82 M(+21.4%) |
| June 2024 | - | -$1.07 M(-18.6%) | -$4.80 M(-7.8%) |
| Mar 2024 | - | -$1.31 M(+15.5%) | -$5.20 M(-4.5%) |
| Dec 2023 | -$5.45 M(-55.8%) | -$1.14 M(-10.7%) | -$5.45 M(-14.9%) |
| Sept 2023 | - | -$1.27 M(-13.7%) | -$6.40 M(-17.1%) |
| June 2023 | - | -$1.48 M(-5.1%) | -$7.72 M(-22.1%) |
| Mar 2023 | - | -$1.56 M(-25.5%) | -$9.91 M(-19.5%) |
| Dec 2022 | -$12.32 M(-21.3%) | -$2.09 M(-19.4%) | -$12.32 M(-14.6%) |
| Sept 2022 | - | -$2.59 M(-29.4%) | -$14.41 M(-9.5%) |
| June 2022 | - | -$3.67 M(-7.3%) | -$15.93 M(-3.7%) |
| Mar 2022 | - | -$3.96 M(-5.4%) | -$16.54 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$15.64 M(+56.3%) | -$4.19 M(+1.9%) | -$15.64 M(-12.5%) |
| Sept 2021 | - | -$4.11 M(-4.0%) | -$17.88 M(+8.8%) |
| June 2021 | - | -$4.28 M(+40.1%) | -$16.43 M(+29.5%) |
| Mar 2021 | - | -$3.06 M(-52.4%) | -$12.68 M(+26.7%) |
| Dec 2020 | -$10.01 M(+359.3%) | -$6.42 M(+141.2%) | -$10.01 M(+141.1%) |
| Sept 2020 | - | -$2.66 M(+394.6%) | -$4.15 M(+86.7%) |
| June 2020 | - | -$538.40 K(+40.7%) | -$2.22 M(+1.9%) |
| Mar 2020 | - | -$382.60 K(-32.4%) | -$2.18 M(+21.3%) |
| Dec 2019 | -$2.18 M(+11.1%) | -$565.70 K(-23.2%) | -$1.80 M(+45.9%) |
| Sept 2019 | - | -$736.30 K(+48.4%) | -$1.23 M(+148.4%) |
| June 2019 | - | -$496.10 K | -$496.10 K |
| Dec 2018 | -$1.96 M | - | - |
FAQ
- What is Virios Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Virios Therapeutics?
- What is Virios Therapeutics annual EBITDA year-on-year change?
- What is Virios Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Virios Therapeutics?
- What is Virios Therapeutics quarterly EBITDA year-on-year change?
- What is Virios Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Virios Therapeutics?
- What is Virios Therapeutics TTM EBITDA year-on-year change?
What is Virios Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VIRI is -$5.45 M
What is the all time high annual EBITDA for Virios Therapeutics?
Virios Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.96 M
What is Virios Therapeutics annual EBITDA year-on-year change?
Over the past year, VIRI annual earnings before interest, taxes, depreciation & amortization has changed by +$6.87 M (+55.77%)
What is Virios Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of VIRI is -$2.30 M
What is the all time high quarterly EBITDA for Virios Therapeutics?
Virios Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$382.60 K
What is Virios Therapeutics quarterly EBITDA year-on-year change?
Over the past year, VIRI quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.03 M (-80.58%)
What is Virios Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of VIRI is -$5.82 M
What is the all time high TTM EBITDA for Virios Therapeutics?
Virios Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$496.10 K
What is Virios Therapeutics TTM EBITDA year-on-year change?
Over the past year, VIRI TTM earnings before interest, taxes, depreciation & amortization has changed by +$575.33 K (+8.99%)